Literature DB >> 35063326

Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic-pituitary-ovarian axis.

Xiaolin Chen1, Zhuoni Xiao2, Yuli Cai1, Lili Huang3, Chen Chen4.   

Abstract

Ovulatory disorders are the most common clinical feature exhibited among obese women. Initiation of ovulation physiologically requires a surge of gonadotropin-releasing hormone (GnRH) released from GnRH neurons located in the hypothalamus. These GnRH neurons receive metabolic signals from circulation and vicinal neurons to regulate GnRH release. Leptin acts indirectly on GnRH via adjacent leptin receptor (LEPR)-expressing neurons such as proopiomelanocortin (POMC), neuropeptide Y (NPY)/agouti-related peptide (AgRP), and neuronal nitric oxide (NO) synthase (nNOS) neurons to affect GnRH neuronal activities. Additionally, hypothalamic inflammation also affects ovulation independent of obesity. Therefore, this review focuses on hypothalamic mechanisms that underlie the disturbance of hypothalamic-pituitary-ovarian (HPO) axis during obesity with an attempt to promote future studies and/or novel therapeutic strategies for ovulatory disorders in obesity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  gonadotropin-releasing hormone; hypothalamic–pituitary–ovarian axis; hypothalamus; leptin; neurons; obesity

Mesh:

Substances:

Year:  2022        PMID: 35063326     DOI: 10.1016/j.tem.2021.12.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   10.586


  2 in total

1.  Ketogenic state improves testosterone serum levels-results from a systematic review and meta-analysis.

Authors:  Chiara Furini; Giorgia Spaggiari; Manuela Simoni; Carla Greco; Daniele Santi
Journal:  Endocrine       Date:  2022-09-23       Impact factor: 3.925

2.  Epigenetic modifier Kdm6a/Utx controls the specification of hypothalamic neuronal subtypes in a sex-dependent manner.

Authors:  Lucas E Cabrera Zapata; María Julia Cambiasso; Maria Angeles Arevalo
Journal:  Front Cell Dev Biol       Date:  2022-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.